The Roseville AI-Native Startup Accelerator 2026 is a good fit for the venture as it focuses on AI-native startups, has a clear timeline, and provides a structured program for validation and prototyping. The accelerator's emphasis on customer interviews, market validation, and iterative building aligns with the venture's goals. The program's location in Downtown Roseville and London also provides access to a network of biopharma companies and experts.